UFP Technologies, Inc. Proceeds from Divestiture of Businesses
UFP Technologies, Inc. (UFPT) reported Proceeds from Divestiture of Businesses of $15.62 million for the 9-month period ending 2022-09-30, per its 10-Q/A filed 2022-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2022-11-14
- 2022-09-30: Proceeds from Divestiture of Businesses 9 month $15.62M.
- 2021-09-30: Proceeds from Divestiture of Businesses 9 month $0.00.
| Period end | Proceeds from Divestiture of Businesses 9 month |
|---|---|
| 2022-09-30 | $15.62M 10-Q/A · filed 2022-11-14 |
| 2021-09-30 | $0.00 10-Q/A · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |